Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 467

    1.

    Resource use and costs of treatment with anticoagulation and antiplatelet agents: results of the WATCH trial economic evaluation.

    Patterson ME, Grant WC, Glickman SW, Massie BM, Ammon SE, Armstrong PW, Cleland JG, Collins JF, Teo KK, Schulman KA, Reed SD.

    J Card Fail. 2009 Dec;15(10):819-27. Epub 2009 Aug 21.PMID: 19944357 [PubMed - in process]Related articles

    2.

    Clinical trials update from the European Society of Cardiology Meeting 2009: AAA, RELY, PROTECT, ACTIVE-I, European CRT survey, German pre-SCD II registry, and MADIT-CRT.

    Cleland JG, Coletta AP, Yassin A, Buga L, Torabi A, Clark AL.

    Eur J Heart Fail. 2009 Dec;11(12):1214-9.PMID: 19926603 [PubMed - in process]Related articles

    3.

    Red cell distribution width: an inexpensive and powerful prognostic marker in heart failure.

    Al-Najjar Y, Goode KM, Zhang J, Cleland JG, Clark AL.

    Eur J Heart Fail. 2009 Dec;11(12):1155-62.PMID: 19926599 [PubMed - in process]Related articles

    4.

    The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study.

    Mebazaa A, Pang PS, Tavares M, Collins SP, Storrow AB, Laribi S, Andre S, Courtney DM, Hasa J, Spinar J, Masip J, Peacock WF, Sliwa K, Gayat E, Filippatos G, Cleland JG, Gheorghiade M.

    Eur Heart J. 2009 Nov 11. [Epub ahead of print]PMID: 19906690 [PubMed - as supplied by publisher]Related articles

    5.

    Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).

    Cleland JG, McMurray JJ, Kjekshus J, Cornel JH, Dunselman P, Fonseca C, Hjalmarson A, Korewicki J, Lindberg M, Ranjith N, van Veldhuisen DJ, Waagstein F, Wedel H, Wikstrand J; CORONA Study Group.

    J Am Coll Cardiol. 2009 Nov 10;54(20):1850-9.PMID: 19892235 [PubMed - indexed for MEDLINE]Related articles

    6.

    Is taking part in clinical trials good for your health? A cohort study.

    Clark AL, Lammiman MJ, Goode K, Cleland JG.

    Eur J Heart Fail. 2009 Nov;11(11):1078-83.PMID: 19875407 [PubMed - in process]Related articles

    7.

    A comparison between monophasic and biphasic defibrillation for the cardioversion of persistent atrial fibrillation in patients with and without heart failure.

    Shelton RJ, Brown BD, Allinson A, Johnson T, Smales C, Jolly S, Cleland JG.

    Int J Cardiol. 2009 Oct 25. [Epub ahead of print]PMID: 19861229 [PubMed - as supplied by publisher]Related articles

    8.

    Lack of Diastolic Reserve in Patients with Heart Failure and Normal Ejection Fraction.

    Chattopadhyay S, Alamgir MF, Nikitin NP, Rigby AS, Clark AL, Cleland JG.

    Circ Heart Fail. 2009 Oct 22. [Epub ahead of print]PMID: 19850696 [PubMed - as supplied by publisher]Related articles

    9.

    Digoxin: quo vadis?

    Cleland JG, Cullington D.

    Circ Heart Fail. 2009 Mar;2(2):81-5. No abstract available. PMID: 19808321 [PubMed - indexed for MEDLINE]Related articles

    10.

    Derivation and validation of a simple clinical risk-model in heart failure based on 6 minute walk test performance and NT-proBNP status - Do we need specificity for sex and beta-blockers?

    Frankenstein L, Goode K, Ingle L, Remppis A, Schellberg D, Nelles M, Katus HA, Clark AL, Cleland JG, Zugck C.

    Int J Cardiol. 2009 Sep 16. [Epub ahead of print]PMID: 19765836 [PubMed - as supplied by publisher]Related articles

    11.

    Effects of carvedilol or metoprolol on PAI-1, tPA-mass concentration or Von Willebrand factor in chronic heart failure - a COMET substudy.

    Boman K, Jansson JH, Nilsson T, Swedberg K, Cleland JG, Poole-Wilson P.

    Thromb Res. 2009 Sep 15. [Epub ahead of print]PMID: 19762071 [PubMed - as supplied by publisher]Related articles

    12.

    Aspirin in the primary prevention of vascular disease.

    Cleland JG.

    Lancet. 2009 Sep 12;374(9693):878; author reply 879. No abstract available. PMID: 19748392 [PubMed - indexed for MEDLINE]Related articles

    13.

    The European cardiac resynchronization therapy survey.

    Dickstein K, Bogale N, Priori S, Auricchio A, Cleland JG, Gitt A, Limbourg T, Linde C, van Veldhuisen DJ, Brugada J; Scientific Committee; National Coordinators.

    Eur Heart J. 2009 Oct;30(20):2450-60. Epub 2009 Aug 31.PMID: 19723694 [PubMed - in process]Related articles

    14.

    Clinical trials update from the European Society of Cardiology heart failure meeting 2009: CHANCE, B-Convinced, CHAT, CIBIS-ELD, and Signal-HF.

    Cleland JG, Coletta AP, Torabi A, Clark AL.

    Eur J Heart Fail. 2009 Aug;11(8):802-5.PMID: 19633104 [PubMed - in process]Related articles

    15.

    Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a sub-analysis of the CARE-HF trial.

    Gervais R, Leclercq C, Shankar A, Jacobs S, Eiskjaer H, Johannessen A, Freemantle N, Cleland JG, Tavazzi L, Daubert C; CARE-HF investigators.

    Eur J Heart Fail. 2009 Jul;11(7):699-705. Epub 2009 Jun 7.PMID: 19505883 [PubMed - in process]Related articles

    16.

    Relationships between cardiac resynchronization therapy and N-terminal pro-brain natriuretic peptide in patients with heart failure and markers of cardiac dyssynchrony: an analysis from the Cardiac Resynchronization in Heart Failure (CARE-HF) study.

    Berger R, Shankar A, Fruhwald F, Fahrleitner-Pammer A, Freemantle N, Tavazzi L, Cleland JG, Pacher R.

    Eur Heart J. 2009 Sep;30(17):2109-16. Epub 2009 Jun 2.PMID: 19493864 [PubMed - in process]Related articles

    18.

    Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group.

    Gheorghiade M, Adams KF, Cleland JG, Cotter G, Felker GM, Filippatos GS, Fonarow GC, Greenberg BH, Hernandez AF, Khan S, Komajda M, Konstam MA, Liu PP, Maggioni AP, Massie BM, McMurray JJ, Mehra M, Metra M, O'Connell J, O'Connor CM, Pang PS, Piña IL, Sabbah HN, Teerlink JR, Udelson JE, Yancy CW, Zannad F, Stockbridge N; Acute Heart Failure Syndromes International Working Group.

    Am Heart J. 2009 Jun;157(6):957-70. No abstract available. PMID: 19464405 [PubMed - indexed for MEDLINE]Related articles

    19.

    Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation.

    Nieuwlaat R, Eurlings LW, Cleland JG, Cobbe SM, Vardas PE, Capucci A, López-Sendòn JL, Meeder JG, Pinto YM, Crijns HJ.

    J Am Coll Cardiol. 2009 May 5;53(18):1690-8.PMID: 19406345 [PubMed - indexed for MEDLINE]Related articles

    20.

    Obituary to Philip Poole-Wilson 1943-2009.

    Cleland JG, Swedberg K.

    Eur J Heart Fail. 2009 May;11(5):529. No abstract available. PMID: 19386815 [PubMed - indexed for MEDLINE]Related articles

    21.

    Impact of different diagnostic criteria on the prevalence and prognostic significance of exertional oscillatory ventilation in patients with chronic heart failure.

    Ingle L, Isted A, Witte KK, Cleland JG, Clark AL.

    Eur J Cardiovasc Prev Rehabil. 2009 Aug;16(4):451-6.PMID: 19369874 [PubMed - indexed for MEDLINE]Related articles

    22.

    Self-rated health and mortality in patients with chronic heart failure.

    Farkas J, Nabb S, Zaletel-Kragelj L, Cleland JG, Lainscak M.

    Eur J Heart Fail. 2009 May;11(5):518-24. Epub 2009 Mar 28.PMID: 19329804 [PubMed - indexed for MEDLINE]Related articles

    23.

    Unconventional end points in cardiovascular clinical trials: should we be moving away from morbidity and mortality?

    Cohn J, Cleland JG, Lubsen J, Borer JS, Steg PG, Perelman M, Zannad F.

    J Card Fail. 2009 Apr;15(3):199-205. Epub 2008 Dec 25.PMID: 19327621 [PubMed - indexed for MEDLINE]Related articles

    24.

    Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial.

    Massie BM, Collins JF, Ammon SE, Armstrong PW, Cleland JG, Ezekowitz M, Jafri SM, Krol WF, O'Connor CM, Schulman KA, Teo K, Warren SR; WATCH Trial Investigators.

    Circulation. 2009 Mar 31;119(12):1616-24. Epub 2009 Mar 16.PMID: 19289640 [PubMed - indexed for MEDLINE]Related articles

    25.

    Long-term left ventricular reverse remodelling with cardiac resynchronization therapy: results from the CARE-HF trial.

    Ghio S, Freemantle N, Scelsi L, Serio A, Magrini G, Pasotti M, Shankar A, Cleland JG, Tavazzi L.

    Eur J Heart Fail. 2009 May;11(5):480-8. Epub 2009 Mar 14.PMID: 19287017 [PubMed - indexed for MEDLINE]Related articles

    26.

    A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).

    Shelton RJ, Clark AL, Goode K, Rigby AS, Houghton T, Kaye GC, Cleland JG.

    Heart. 2009 Jun;95(11):924-30. Epub 2009 Mar 11.PMID: 19282313 [PubMed - indexed for MEDLINE]Related articles

    27.

    Predicting hospitalization due to worsening heart failure using daily weight measurement: analysis of the Trans-European Network-Home-Care Management System (TEN-HMS) study.

    Zhang J, Goode KM, Cuddihy PE, Cleland JG; TEN-HMS Investigators.

    Eur J Heart Fail. 2009 Apr;11(4):420-7. Epub 2009 Feb 28.PMID: 19252210 [PubMed - indexed for MEDLINE]Related articles

    28.

    Effects of cardiac resynchronization therapy on long-term quality of life: an analysis from the CArdiac Resynchronisation-Heart Failure (CARE-HF) study.

    Cleland JG, Calvert MJ, Verboven Y, Freemantle N.

    Am Heart J. 2009 Mar;157(3):457-66. Epub 2009 Jan 20.PMID: 19249415 [PubMed - indexed for MEDLINE]Related articles

    29.

    Elevated glycated haemoglobin is a strong predictor of mortality in patients with left ventricular systolic dysfunction who are not receiving treatment for diabetes mellitus.

    Goode KM, John J, Rigby AS, Kilpatrick ES, Atkin SL, Bragadeesh T, Clark AL, Cleland JG.

    Heart. 2009 Jun;95(11):917-23. Epub 2009 Feb 19.PMID: 19233773 [PubMed - indexed for MEDLINE]Related articles

    30.

    Telemonitoring for heart failure: the only feasible option for good universal care?

    Cleland JG, Lewinter C, Goode KM.

    Eur J Heart Fail. 2009 Mar;11(3):227-8. No abstract available. PMID: 19228799 [PubMed - indexed for MEDLINE]Related articles

    31.

    Cardiac resynchronization therapy: are modern myths preventing appropriate use?

    Cleland JG, Tavazzi L, Daubert JC, Tageldien A, Freemantle N.

    J Am Coll Cardiol. 2009 Feb 17;53(7):608-11. No abstract available. PMID: 19215836 [PubMed - indexed for MEDLINE]Related articles

    32.

    The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction.

    Kubánek M, Goode KM, Lánská V, Clark AL, Cleland JG.

    Eur J Heart Fail. 2009 Apr;11(4):367-77. Epub 2009 Jan 29.PMID: 19179406 [PubMed - indexed for MEDLINE]Related articles

    33.

    Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide.

    Wedel H, McMurray JJ, Lindberg M, Wikstrand J, Cleland JG, Cornel JH, Dunselman P, Hjalmarson A, Kjekshus J, Komajda M, Kuusi T, Vanhaecke J, Waagstein F; CORONA Study Group.

    Eur J Heart Fail. 2009 Mar;11(3):281-91. Epub 2009 Jan 24.PMID: 19168876 [PubMed - indexed for MEDLINE]Related articles

    34.

    The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial.

    Wikstrom G, Blomström-Lundqvist C, Andren B, Lönnerholm S, Blomström P, Freemantle N, Remp T, Cleland JG; CARE-HF study investigators.

    Eur Heart J. 2009 Apr;30(7):782-8. Epub 2009 Jan 24.PMID: 19168870 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Years-needed-to-treat to add 1 year of life: a new metric to estimate treatment effects in randomized trials.

    Levy WC, Mozaffarian D, Linker DT, Kenyon KW, Cleland JG, Komajda M, Remme WJ, Torp-Pedersen C, Metra M, Poole-Wilson PA; COMET Investigators.

    Eur J Heart Fail. 2009 Mar;11(3):256-63. Epub 2009 Jan 22.PMID: 19164422 [PubMed - indexed for MEDLINE]Related articles

    37.

    Levosimendan vs. dobutamine: outcomes for acute heart failure patients on beta-blockers in SURVIVE.

    Mebazaa A, Nieminen MS, Filippatos GS, Cleland JG, Salon JE, Thakkar R, Padley RJ, Huang B, Cohen-Solal A.

    Eur J Heart Fail. 2009 Mar;11(3):304-11. Epub 2009 Jan 21.PMID: 19158152 [PubMed - indexed for MEDLINE]Related articles

    38.

    The prognostic value of individual NT-proBNP values in chronic heart failure does not change with advancing age.

    Frankenstein L, Clark AL, Goode K, Ingle L, Remppis A, Schellberg D, Grabs F, Nelles M, Cleland JG, Katus HA, Zugck C.

    Heart. 2009 May;95(10):825-9. Epub 2009 Jan 15.PMID: 19147626 [PubMed - indexed for MEDLINE]Related articles

    39.

    Smoking cessation in heart failure: easier said than done.

    Lainscak M, Anker SD, Cleland JG.

    Eur Heart J. 2009 Mar;30(5):624-5; author reply 625. Epub 2009 Jan 15. No abstract available. PMID: 19147606 [PubMed - indexed for MEDLINE]Related articles

    40.

    POPADAD trial. Time for a proper study of aspirin after a vascular event?

    Cleland JG.

    BMJ. 2008 Nov 19;337:a2583. doi: 10.1136/bmj.a2583. No abstract available. PMID: 19019865 [PubMed - indexed for MEDLINE]Related articles

    41.

    Clinical trials update from European Society of Cardiology meeting 2008: TIME-CHF, BACH, BEAUTIFUL, GISSI-HF, and HOME-HF.

    Coletta AP, Cullington D, Clark AL, Cleland JG.

    Eur J Heart Fail. 2008 Dec;10(12):1264-7. Epub 2008 Nov 12.PMID: 19008149 [PubMed - indexed for MEDLINE]Related articles

    42.

    [Heart failure in men and women: important differences in the diagnostic workup and treatment]

    Lenzen MJ, Rosengren A, Scholte op Reimer WJ, Follath F, Boersma E, M L S, Cleland JG, Komajda M.

    Ned Tijdschr Geneeskd. 2008 Oct 4;152(40):2182-5. Dutch. PMID: 18953781 [PubMed - indexed for MEDLINE]Related articles

    43.

    Oral levosimendan in patients with severe chronic heart failure --the PERSIST study.

    Nieminen MS, Cleland JG, Eha J, Belenkov Y, Kivikko M, Põder P, Sarapohja T.

    Eur J Heart Fail. 2008 Dec;10(12):1246-54. Epub 2008 Oct 21.PMID: 18945637 [PubMed - indexed for MEDLINE]Related articles

    44.

    Predictors of mortality from pump failure and sudden cardiac death in patients with systolic heart failure and left ventricular dyssynchrony: results of the CARE-HF trial.

    Uretsky BF, Thygesen K, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, Cleland JG.

    J Card Fail. 2008 Oct;14(8):670-5. Epub 2008 Jul 15.PMID: 18926439 [PubMed - indexed for MEDLINE]Related articles

    45.

    Interpretation of amino-terminal pro-brain natriuretic peptide levels in the HPS and the CORONA study.

    Cleland JG, Squire I, Ng L.

    J Am Coll Cardiol. 2008 Sep 23;52(13):1104-5. No abstract available. PMID: 18848145 [PubMed - indexed for MEDLINE]Related articles

    46.

    Cardiac resynchronization therapy: dyssynchrony imaging from a heart failure perspective.

    Cleland JG, Cullington D, Khaleva O, Tageldien A.

    Curr Opin Cardiol. 2008 Nov;23(6):634-45. Review.PMID: 18830081 [PubMed - indexed for MEDLINE]Related articles

    47.

    Predictors of short term mortality in heart failure - insights from the Euro Heart Failure survey.

    Velavan P, Khan NK, Goode K, Rigby AS, Loh PH, Komajda M, Follath F, Swedberg K, Madeira H, Cleland JG.

    Int J Cardiol. 2010 Jan 7;138(1):63-9. Epub 2008 Sep 11.PMID: 18789548 [PubMed - in process]Related articles

    48.

    State of the art: using natriuretic peptide levels in clinical practice.

    Maisel A, Mueller C, Adams K Jr, Anker SD, Aspromonte N, Cleland JG, Cohen-Solal A, Dahlstrom U, DeMaria A, Di Somma S, Filippatos GS, Fonarow GC, Jourdain P, Komajda M, Liu PP, McDonagh T, McDonald K, Mebazaa A, Nieminen MS, Peacock WF, Tubaro M, Valle R, Vanderhyden M, Yancy CW, Zannad F, Braunwald E.

    Eur J Heart Fail. 2008 Sep;10(9):824-39. Epub 2008 Aug 29. Review.PMID: 18760965 [PubMed - indexed for MEDLINE]Related articles

    49.

    Clinical trials update from Heart Rhythm 2008 and Heart Failure 2008: ATHENA, URGENT, INH study, HEART and CK-1827452.

    Coletta AP, Cleland JG, Cullington D, Clark AL.

    Eur J Heart Fail. 2008 Sep;10(9):917-20. Epub 2008 Aug 3.PMID: 18678526 [PubMed - indexed for MEDLINE]Related articles

    50.

    Changes in body composition in patients with left ventricular systolic dysfunction initiated on beta-blocker therapy.

    Ingle L, Rigby AS, Carroll S, Butterly R, King RF, Cooke CB, Cleland JG, Clark AL.

    Exp Clin Cardiol. 2007 Spring;12(1):46-7.PMID: 18650980 [PubMed - in process]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...